Wells Fargo’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $732K | Sell |
16,853
-1,251
| -7% | -$54.3K | ﹤0.01% | 3546 |
|
|
2025
Q1 | $676K | Buy |
18,104
+399
| +2% | +$14.9K | ﹤0.01% | 3479 |
|
|
2024
Q4 | $802K | Sell |
17,705
-80,585
| -82% | -$3.65M | ﹤0.01% | 3418 |
|
|
2024
Q3 | $5.77M | Buy |
98,290
+86,710
| +749% | +$5.09M | ﹤0.01% | 2025 |
|
|
2024
Q2 | $456K | Sell |
11,580
-1,848
| -14% | -$72.7K | ﹤0.01% | 3629 |
|
|
2024
Q1 | $892K | Buy |
13,428
+7,570
| +129% | +$503K | ﹤0.01% | 3211 |
|
|
2023
Q4 | $164K | Buy |
5,858
+1,455
| +33% | +$40.7K | ﹤0.01% | 4203 |
|
|
2023
Q3 | $93.8K | Buy |
+4,403
| New | +$93.8K | ﹤0.01% | 4482 |
|